SCHEMBL30953237

SCHEMBL30953237

COCC(=O)c1ccnc(NC(=O)[C@@H](NC(=O)OC(C)(C)C)C2CCC(C)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 7/20 0.46
▸ ACACB O00763 1/20 0.35
▸ ACACA Q13085 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ GSK3B P49841 7/20 0.34
▸ GSK3A P49840 3/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPT P10636 4/20 0.33
▸ MMP1 P03956 1/20 0.33
▸ PSEN1 P49768 1/20 0.33
▸ PSEN2 P49810 1/20 0.33
▸ APH1B Q8WW43 1/20 0.33
▸ NCSTN Q92542 1/20 0.33
▸ APH1A Q96BI3 1/20 0.33
▸ PSENEN Q9NZ42 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30953508 0.89 AAK1 (0.42) AAK1ACACBACACAHIF1AGSK3B
SCHEMBL30953440 0.84 AAK1 (0.51) AAK1ACACBACACALMNARAB9A
SCHEMBL27393615 0.83 AAK1 (0.48) AAK1ACACBACACALMNARAB9A
SCHEMBL30953221 0.83 AAK1 (0.48) AAK1ACACBACACALMNARAB9A
SCHEMBL30953307 0.83 AAK1 (0.45) AAK1ACACBACACALMNARAB9A
SCHEMBL30953402 0.83 AAK1 (0.60) AAK1LMNARAB9AGSK3BMMP1
SCHEMBL30953339 0.83 AAK1 (0.50) AAK1ACACBACACALMNARAB9A
SCHEMBL30953269 0.81 AAK1 (0.48) AAK1ACACBACACALMNARAB9A
SCHEMBL27393638 0.81 AAK1 (0.48) AAK1ACACBACACALMNARAB9A
SCHEMBL30953381 0.81 AAK1 (0.46) AAK1ACACBACACALMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback